CC B Ó-NC . Licence É Copyright 22 EMJ É August 22 É Neurology 51 Meeting Summary Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless ...
Factor XI/XIa Inhibitors: What We Now Know
Oct 18, 2024 · Downstream, the pathways are indistinguishable, so targeting downstream elements like factor Xa or thrombin (or their precursors factor X and prothrombin), as the …
CC BY-NC 4. Licence É Copyright 4 EM É Article first line anti-tuberculosis drugs in
26 Neurology May 2024 Creative Commons Attribution-Non Commercial 4.0 Poster Review Introduction Ozanimod is a modulator of spingosine-1-phosphate (S1P) receptor 1 and 5. It is …
ERS 2024 Abstract Highlights - European Medical Journal
Oct 22, 2024 · The following abstract highlights spotlight selected abstracts presented at the European Respiratory Society (ERS) Congress 2024. They cover key topics, including lung …
Atopic Dermatitis: An Interactive Case - European Medical Journal
Sep 1, 2022 · In this interactive medical case study, the patient is a 10-month-old child with moderate atopic dermatitis. The case details share the patient’s medical and family history, …
New Psoriasis Antibody Treatment Shows Exceptional Clinical Results
Dec 24, 2024 · PSORIASIS, a chronic immune-mediated skin condition, poses a significant challenge for patients, with an ongoing unmet need for effective biologic treatments. To …
EMJ | Elevating the quality of healthcare globally
Our independent, open-access journals are dedicated to delivering insights into ground-breaking changes and advancements in medicine
30 EM Ø September 2024 Ø Copyright 2024 EM Ø CC BY-NC 4.0 Licence Clinical Practice Insights for Hyperpigmentation Treatment Interview Summary Hyperpigmentation ...
The Effect of Exposure to Radiofrequency Fields on Cancer Risk
Oct 20, 2024 · A recent comprehensive review of human observational studies found no strong evidence linking radiofrequency electromagnetic fields (RF-EMF) from mobile phones and …